How to treat antipsychotic‐related weight gain and metabolic disturbances: Is there a role for GLP ‐1 receptor agonists?

Documenti analoghi

• Letter to the Editor Concerning “Glucagon‐Like Peptide Agonists for Weight Management in Antipsychotic‐Induced Weight Gain: A Systematic Review and Meta‐Analysis”
  di: Anders Fink‐Jensen, et al.
  Pubblicazione: (2024)
• Who is at risk for weight gain after weight‐gain associated treatment with antipsychotics, antidepressants, and mood stabilizers: A machine learning approach
  di: Julia Eder, et al.
  Pubblicazione: (2024)
• Life Expectancy, Loss of Life Expectancy, and Lifetime Costs in Bipolar Disorder: A Nationwide Population‐Based Study
  di: Ikbal Andrian Malau, et al.
  Pubblicazione: (2025)
• Dosing levels of antipsychotics and mood stabilizers in bipolar disorder: A Nationwide cohort study on relapse risk and treatment safety
  di: Jonne Lintunen, et al.
  Pubblicazione: (2024)
• Efficacy and Acceptability of Licensed and Off‐Label Pharmacological Interventions for Insomnia in Patients With Severe Mental Illness: A Systematic Review and Meta‐Analysis of Randomised Trials
  di: Nina Friis Bak Fuglsang, et al.
  Pubblicazione: (2025)